Researchers have been excited about the medication , a innovative dual agonist showing remarkable outcomes in early trials for weight loss . It functions by impacting both pathways : GLP-1 and GIP, that https://isaiahrtdc498214.blogdanica.com/40959671/a-new-prospect-for-size-loss